Mutations in immunodominant T cell epitopes derived from the nonstructural 3 protein of hepatitis C virus have the potential for generating escape variants that may have important consequences for T cell recognition

Journal of Immunology

Volumn 162, Issue 7, 1999, Pages 4177-4183

  Wang, Huiru ^a   Eckels, David D ^a  

^a BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; EPITOPE; INTERLEUKIN 10; INTERLEUKIN 2; SYNAPSIN II;

ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA FLANKING REGION; HEPATITIS C VIRUS; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MUTATION RATE; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS MUTATION;

EID: 0033120555     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Choo, Q. L., G. Kuo, A. J. Weiner, L. R. Overby, D. W. Bradley, and M. Houghton. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359.
2. Mosmann, T. R., and R. L. Coffman. 1998. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
3. Muller, H. M., E. Pfaff, T. Goeser, B. Kallinowski, C. Solbach, and L. Theilmann. 1993. Peripheral blood leukocytes serve as a possible extrahepatic site for hepatitis C virus replication. J Gen. Virol. 74:669.
4. Sherman, P. A., P. V. Basta, and J. P. Ting. 1987. Upstream DNA sequences required for tissue-specific expression of the HLA-DR α gene. Proc. Natl. Acad. Sci. USA 84:4254.
5. Cowan, E. P., M. L. Jelachic, J. E. Coligan, and W. E. Biddison. 1987. Site-directed mutagenesis of an HLA-A3 gene identifies amino acid 152 as crucial for major-histocompatibility-complex-restricted and alloreactive cytotoxic-T-lymphocyte recognition. Proc. Natl. Acad. Sci. USA 84:5014.
6. Plagemann, P. G. W. 1991. Hepatitis C virus. Arch. Virol. 120:165.
7. Resnick, R. H., and R. Koff. 1993. Hepatitis C-related hepatocellular carcinoma: prevalence and significance. Arch. Int. Med. 153:1672.
8. Misiani, R., P. Bellavita, D. Fenili, O. Vicari, D. Marchesi, P. L. Sironi, P. Zilio, A. Vernocchi, M. Massazza, G. Vendramin, E. Tanzi, and A. Zanetti. 1994. Interferon α-2a therapy in cryoglobulinemia associated with hepatitis C virus. N. Eng. J. Med. 130:751.
9. Thiele, D. L. 1990. Implications of anti-hepatitis C reactivity in "autoimmune" chronic active hepatitis. Gastroenterology 99:1531.
10. McFarlane, B. M., C. Bridger, C. J. Tibbs, M. G. Saleh, A. Fuzio, G. Verucchi, L. Attard, A. Boschi, F. Chiodo, I. G. McFarlane, and R. Williams. 1994. Virus-induced autoimmunity in hepatitis C virus infections: a rare event. J. Med. Virol. 42:66.
11. Grakoui, A., D. W. McCourt, C. Wychowski, S. M. Feinstone, and C. M. Rice. 1993. Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites. J. Virol. 67:2832.
12. Morgenstem, K. A., J. A. Landro, K. Hsiao, C. Lin, Y. Gu, M. S. Su, and J. A. Thomson. 1997. Polynucleotide modulation of the protease, nucleoside triphosphatase, and helicase activities of a hepatitis C virus NS3-NS4A complex isolated from transfected COS cells. J. Virol. 71:3767.
13. Jin, L., and D. L. Peterson. 1995. Expression, isolation, and characterization of the hepatitis C virus ATPase/RNA helicase. Arch. Biochem. Biophys. 323: 47.
14. Hijikata, M., H. Mizushima, T. Akagi, S. Mori, N. Kakiuchi, N. Kato, T. Tanaka, K. Kimura, and K. Shimotohno. 1993. Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. J. Virol. 67:4665.
15. Manabe, S., I. Fuke, O. Tanishita, C. Kaji, Y. Gomi, S. Yoshida, C. Mori, A. Takamizawa, I. Yosida, and H. Okayama. 1994. Production of nonstructural proteins of hepatitis C virus requires a putative viral protease encoded by NS3. Virology 198:636.
16. Shirai, M., T. Akatsuka, C. D. Pendleton, R. Houghten, C. Wychowski, K. Mihalik, S. Feinstone, and J. A. Berzofsky. 1992. Induction of cytotoxic T cells to a cross-reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like protein. J. Virol. 66:4098.
17. Ferrari, C., A. Valli, L. Galati, A. Penna, P. Scaccaglia, T. Giuberti, C. Schianchi, G. Missale, M. G. Marin, and F. Fiaccadori. 1994. T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology 19:286.
18. Botarelli, P., M. R. Brunetto, M. A. Minutello, P. Calvo, D. Unutmaz, A. J. Weiner, Q. L. Choo, J. R. Shuster, G. Kuo, F. Bonino, M. Houghton, and S. Abrignani. 1993. T-lymphocyte responses to hepatitis C virus in different courses of infection. Gastroenterology 104:580.
19. Eckels, D. D., P. Flomenberg, and J. C. Gill. 1996. Hepatitis C virus: models of immunopathogenesis and prophylaxis. Transfusion 36:836.
20. Klenerman, P., S. Rowland-Jones, S. McAdam, J. Edwards, S. Daenke, D. Lalloo, B. Koppe, W. Rosenberg, D. Boyd, A. Edwards, et al. 1994. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature 369:403.
21. Tabatabai, N., T. H. Bian, C. M. Rice, K. Yoshizawa, J. Gill, and D. D. Eckels. 1999. Functionally distinct T-cell epitopes within the Hepatitis C Virus nonstructural 3 protein. Hum. Immunol. 60:105.
22. Yoshioka, K., S. Kakumu, T. Wakita, T. Ishikawa, Y. Itoh, M. Takayanagi, Y. Higashi, M. Shibata, and T. Morishima. 1992. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-α therapy: relationship to genotypes of hepatitis C virus. Hepatology 16:293.
23. Grakoui, A., C. Wychowski, C. Lin, S. M. Feinstone, and C. M. Rice. 1993. Expression and identification of hepatitis C virus polyprotein cleavage products. J. Virol. 67:1385.
24. Smith, D. B., J. McAllister, C. Casino, and P. Simmondz. 1997. Virus "quasi-species": making a mountain out of a molehill? J. Gen. Virol. 78:1511.
25. Lundberg, K. S., D. D. Shoemaker, M. W. W. Adams, J. M. Short, J. A. Sorge, and B. J. Mathur. 1991. High-fidelity amplification using a thermostable DNA polymerase isolated from Pyrococcuss furiosus. Gene 108:1.
26. Barnes, W. M. 1992. The fidelity of Taq polymerase catalyzing PCR is improved by an N-terminal deletion. Gene 112:29.
27. Weiner, A. J., H. M. Geysen, C. Christopherson, J. E. Hall, T. J. Mason, G. Saracco, F. Bonino, K. Crawford, C. D. Marion, K. A. Crawford, et al. 1992. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc. Natl. Acad. Sci. USA 89:3468.
28. Bertoletti, A., A. Sette, F. V. Chisari, A. Penna, M. Levrero, M. De Carli, F. Fiaccadori, and C. Ferrari. 1994. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 369: 407.
29. Archibald, A. L., N. A. Thompson, and S. Kvist. 1986. A single nucleotide difference at the 3′ end of an intron causes differential splicing of two histocompatibility genes. EMBO J. 5:957.
30. Hughes, A. L., and M. Nei. 1989. Nucleotide substitution at major histocompatibility complex class II loci: evidence for overdominant selection. Proc. Natl. Acad. Sci. USA 86:958.
31. Martin, M. J., J. I. Nunez, F. Sobrino, and J. Dopazo. 1998. A procedure for detecting selection in highly variable viral genomes: evidence of positive selection in antigenic regions of capsid protein VPI of foot-and-mouth disease virus. J. Virol. Meth. 74:215.
32. Moore, K. W., A. O'Garra, M. R. de Waal, P. Vieira, and T. R. Mosmann. 1993. Interleukin-10. Annu. Rev. Immunol. 11:165.
33. Eckels, D. D., N. Tabatabai, T.-H. Bian, H. Wang, S. S. Muheisen, C. M. Rice, K. Yoshizawa, and J. Gill. 1998. In vitro human Th-cell responses to a recombinant hepatitis C virus antigen: failure in IL-2 production despite proliferation. Hum. Immunol. In press.
34. Gooding, L. R. 1992. Virus proteins that counteract host immune defenses. Cell 71:5.